On account of the prior attraction of BCR-ABL1 fusion, the latent clone mutation may play a leading role, developing into MDS/AML when the BCR-ABL1 fusion oncogene disappears or the Ph chromosome becomes negative. The gene discussed is BCR; the disease is myelodysplastic syndrome.